Suliqua is a medicine that is used together with metformin (another diabetes medicine), with or without SGLT-2 inhibitors (other diabetes medicines), for the treatment of adults with type 2 diabetes. It is used with appropriate diet and exercise to improve control of blood glucose (sugar) when the diabetes is not satisfactorily controlled. The active substances in Suliqua are insulin glargine and lixisenatide.
Therapeutic Indication
### Therapeutic indication Suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without SGLT-2 inhibitors.
Therapeutic Area (MeSH)
N/AATC Code
A10AE54
ATC Item
insulin glargine and lixisenatide
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
N/AINN / Common Names
N/AEMA Name
Suliqua
Medicine Name
Suliqua
Aliases
N/ANo risk management plan link.
